Pamela Joan Theobald

Title: The Innovations of Pamela Joan Theobald

Introduction

Pamela Joan Theobald is a notable inventor based in Essex, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological and psychiatric conditions. Her work has the potential to improve the quality of life for many individuals suffering from cognitive impairments and sleep disorders.

Latest Patents

Theobald holds a patent for a piperazine derivative that has an affinity for the histamine H3 receptor. The patent describes the compound 1-(1-methylethyl)-4-{[4-(tetrahydro-2H-pyran-4-yloxy)phenyl]carbonyl}piperazine, or a pharmaceutically acceptable salt thereof, specifically the hydrochloride salt. This invention includes processes for preparing the compound, its compositions, and its applications in treating neurological or psychiatric diseases, such as cognitive impairment, fatigue, or sleep disorders.

Career Highlights

Theobald is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. Her work there has focused on innovative solutions to complex health issues, showcasing her dedication to advancing medical science.

Collaborations

Throughout her career, Theobald has collaborated with esteemed colleagues, including Desmond John Best and Sing Yeung Mak. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Pamela Joan Theobald's contributions to the field of pharmaceuticals through her innovative patent demonstrate her commitment to improving health outcomes. Her work continues to inspire advancements in the treatment of neurological and psychiatric disorders.